Drugs by condition
Drugs approved for insomnia
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
16
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
10
New molecular entities and new biologics
In development
7
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for insomnia.
- Zolpidem Tartrate (Zolpidem Tartrate) · Almatica May 9, 2023
- Quviviq (Daridorexant Hydrochloride) · Idorsia NovelJan 7, 2022
- Dayvigo (Lemborexant) · Eisai INC NovelDec 20, 2019
- Mydayis (Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate) · Takeda Pharms USA Jun 20, 2017
- Belsomra (Suvorexant) · Merck Sharp Dohme NovelAug 13, 2014
All approved drugs for insomnia, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 111 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Orexin Receptor Antagonist (3)
Benzodiazepine (3)
Melatonin Receptor Agonist (1)
- Rozerem Ramelteon · Takeda Pharms USA · 2005
Monoamine Oxidase Inhibitor (1)
- Marplan Isocarboxazid · Lifsa Drugs · 1959
Class not listed in FDA's data (8)
- Lunesta Eszopiclone · Waylis Therap · 2004
- Ambien Zolpidem Tartrate · Cosette · 1992
- Zolpidem Tartrate Zolpidem Tartrate · Almatica · 2023
- Mydayis Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate · Takeda Pharms USA · 2017
- Silenor Doxepin Hydrochloride · Currax · 2010
- Edluar Zolpidem Tartrate · Viatris · 2009
- Venlafaxine Hydrochloride Venlafaxine Hydrochloride · Osmotica Pharm US · 2008
- Ambien Cr Zolpidem Tartrate · Cosette · 2005
Drugs in development for insomnia
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- HS-10506Phase 32 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Insomnia Disorder
- YZJ-1139Phase 31 trial
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Insomnia Disorder
- RE03Phase 21 trial
Reconnect Labs · Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia
- SOM001-APhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SOM001-BPhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SOM001-CPhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
- SOM001-DPhase 21 trial
Somnum Pharma Inc. · Chronic Insomnia
More on insomnia: recruiting trials · published research
Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · ADHD · Anxiety disorders · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.